Afya Faculdade de Ciências Médicas de Marabá · Método Científico em Medicina IV

Resistência à insulina e manifestações psiquiátricas em mulheres com síndrome dos ovários policísticos: uma revisão sistemática

Referências citadas na apresentação do projeto de pesquisa de Ana Lidia Voltolini Pelicho, Andrea Luiza Vitoriano dos Santos, Grazielly Macêdo Alves, Maria Eduarda Lima França Silva e Stefanni Chaves de Freitas. Orientador: Prof. Me. Paula Gabrielle Gomes Cândido. Marabá/PA, 2026.
  1. ABDALLA, M. A. et al. Impact of pharmacological interventions on insulin resistance in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Clinical Endocrinology, v. 96, n. 6, p. 795-804, 2022.
  2. ATINGA, A. et al. Depression and anxiety among women with polycystic ovarian syndrome in low- and middle-income countries: a systematic review and meta-analysis. Frontiers in Global Women's Health, v. 6, p. 1688913, 2025. DOI: 10.3389/fgwh.2025.1688913.
  3. BRASIL. Ministério da Saúde. Secretaria de Atenção à Saúde. Departamento de Ações Programáticas Estratégicas. Política Nacional de Atenção Integral à Saúde da Mulher: princípios e diretrizes. Brasília, DF: Ministério da Saúde, 2004.
  4. COONEY, L. G. et al. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis. Human Reproduction, v. 32, n. 5, p. 1075-1091, 2017. DOI: 10.1093/humrep/dex044.
  5. COONEY, L. G. et al. Psychiatric disorders in women with polycystic ovary syndrome: a systematic review and meta-analysis. Fertility and Sterility, v. 109, n. 1, p. 137-145, 2018. DOI: 10.1016/j.fertnstert.2017.10.022.
  6. COONEY, L. G. et al. Increased prevalence of binge eating disorder and bulimia nervosa in women with polycystic ovary syndrome: a systematic review and meta-analysis. The Journal of Clinical Endocrinology & Metabolism, v. 109, n. 12, p. 3293-3305, 2024. DOI: 10.1210/clinem/dgae462.
  7. INFANTE-CANO, M. et al. The prevalence and risk of anxiety and depression in polycystic ovary syndrome: an overview of systematic reviews with meta-analysis. Archives of Women's Mental Health, v. 28, n. 3, p. 475-489, 2025. DOI: 10.1007/s00737-024-01526-1.
  8. JANSSEN, J. A. M. J. L. New insights into the role of insulin and hypothalamic-pituitary-adrenal (HPA) axis in the metabolic syndrome. International Journal of Molecular Sciences, v. 23, n. 15, p. 8178, 2022. DOI: 10.3390/ijms23158178.
  9. KARAMPELA, A. I.; DRUCE, M. The relationship between polycystic ovary syndrome (PCOS) and depression. Clinical Endocrinology, v. 105, p. 131-140, 2026.
  10. KIM, J. J. et al. Prevalence of insulin resistance in Korean women with polycystic ovary syndrome according to various homeostasis model assessment for insulin resistance cutoff values. Fertility and Sterility, v. 112, n. 5, p. 959-966, 2019. DOI: 10.1016/j.fertnstert.2019.06.035.
  11. MEZZULLO, M. et al. Salivary cortisol and cortisone responses to short-term psychological stress challenge in late adolescent and young women with different hyperandrogenic states. Psychoneuroendocrinology, v. 91, p. 31-40, 2018. DOI: 10.1016/j.psyneuen.2018.02.022.
  12. MILLER, A. H.; HAROON, E.; RAISON, C. L.; FELGER, J. C. Cytokine targets in the brain: impact on neurotransmitters and neurocircuits. Depression and Anxiety, v. 30, n. 4, p. 297-306, 2013. DOI: 10.1002/da.22084.
  13. ROTTERDAM ESHRE/ASRM-SPONSORED PCOS CONSENSUS WORKSHOP GROUP. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction, v. 19, n. 1, p. 41-47, 2004. DOI: 10.1093/humrep/deh098.
  14. RUDNICKA, E. et al. Chronic low grade inflammation in pathogenesis of PCOS. International Journal of Molecular Sciences, v. 22, n. 7, p. 3789, 2021. DOI: 10.3390/ijms22073789.
  15. SHAHRAKI, Z.; RASTKAR, M.; RAMEZANPOUR, M.-R.; GHAJARZADEH, M. The prevalence and odds of bipolar disorder in women with polycystic ovary syndrome (PCO) disease: a systematic review and meta-analysis. Archives of Women’s Mental Health, v. 27, n. 3, p. 329-336, 2024. DOI: 10.1007/s00737-024-01420-w.
  16. SPRITZER, P. M. et al. Prevalence and characteristics of polycystic ovary syndrome in Brazilian women: protocol for a nation-wide case-control study. BMJ Open, v. 9, n. 10, p. e029191, 2019. DOI: 10.1136/bmjopen-2019-029191.
  17. SPRITZER, P. M. et al. Lifestyle, anxiety, depression, and clinical profile in women with polycystic ovary syndrome: initial results from the Brazilian PCOS study. Journal of the Endocrine Society, v. 5, supl. 1, p. A741, 2021. DOI: 10.1210/jendso/bvab048.1507.
  18. STEFANAKI, K. et al. Obesity and hyperandrogenism are implicated with anxiety, depression and food cravings in women with polycystic ovary syndrome. Endocrine, v. 82, n. 1, p. 201-208, 2023.
  19. TEEDE, H. J. et al. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Human Reproduction, v. 38, n. 9, p. 1655-1679, 2023. DOI: 10.1093/humrep/dead156.
  20. TEEDE, H. J. et al. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. The Lancet, v. 407, p. 2329-2340, 2026.
  21. WANG, D. et al. P2X7 receptor mediates NLRP3 inflammasome activation in depression and diabetes. Cell & Bioscience, v. 10, n. 28, p. 1-13, 2020. DOI: 10.1186/s13578-020-00388-1.
  22. WORLD HEALTH ORGANIZATION. Regional Office for Europe. WHO European Regional Obesity Report 2022. Copenhagen: WHO Regional Office for Europe, 2022.
  23. ZHU, S.; LI, Z.; HU, C.; SUN, F.; WANG, C.; YUAN, H.; LI, Y. Imaging-based body fat distribution in polycystic ovary syndrome: a systematic review and meta-analysis. Frontiers in Endocrinology, v. 12, p. 697223, 2021. DOI: 10.3389/fendo.2021.697223.